BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20135135)

  • 1. Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.
    Zekioglu O; Ozdemir N; Terek C; Ozsaran A; Dikmen Y
    Arch Gynecol Obstet; 2010 Dec; 282(6):671-6. PubMed ID: 20135135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The morphologic and immunohistochemical spectrum of 16 cases of sclerosing stromal tumor of the ovary.
    Qureshi A; Raza A; Kayani N
    Indian J Pathol Microbiol; 2010; 53(4):658-60. PubMed ID: 21045387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathogenesis of sclerosing stromal tumor of the ovary: a neoplasm in transition.
    Roth LM; Gaba AR; Cheng L
    Int J Gynecol Pathol; 2014 Sep; 33(5):449-62. PubMed ID: 25083960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing stromal tumour of the ovary: two case reports.
    Limaiem F; Boudabous E; Ben Slama S; Chelly B; Lahmar A; Bouraoui S; Gara F; Mzabi S
    Pathologica; 2013 Apr; 105(2):62-5. PubMed ID: 23951586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of angiogenic factors in sclerosing stromal tumours of the ovary.
    Hirakawa T; Kawano Y; Mizoguchi C; Nasu K; Narahara H
    J Obstet Gynaecol; 2018 Jul; 38(5):682-685. PubMed ID: 29433373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerosing stromal tumor of the ovary: MR-pathologic correlation in three cases.
    Kim JY; Jung KJ; Chung DS; Kim OD; Lee JH; Youn SK
    Korean J Radiol; 2003; 4(3):194-9. PubMed ID: 14530650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing stromal tumor of the ovary in a 4-year-old girl with characteristics of an ovarian signet-ring stromal tumor.
    He Y; Yang KX; Jiang W; Wang DQ; Li L
    Pathol Res Pract; 2010 May; 206(5):338-41. PubMed ID: 19604650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine needle aspiration cytology in sclerosing stromal tumor of the ovary: a series of three cases.
    Banik T; Gupta N; Dey P; Rajwanshi A; Dhaliwal LK
    Diagn Cytopathol; 2012 Apr; 40(4):342-5. PubMed ID: 21630480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing stromal tumour of the ovary.
    Kumar RV; Mukherjee G; Umadevi K; Hazarika D
    Indian J Cancer; 1994 Jun; 31(2):92-5. PubMed ID: 7927455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing stromal tumor: an important differential diagnosis of ovarian neoplasms in childhood and adolescence.
    Gwin K; Mariño-Enríquez A; Martel M; Reyes-Múgica M
    Pediatr Dev Pathol; 2009; 12(5):366-70. PubMed ID: 19071970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing stromal tumour of the ovary--a case report.
    Gupta S
    Indian J Pathol Microbiol; 1999 Jan; 42(1):97-9. PubMed ID: 10420692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerosing stromal tumor of the ovary.
    Iravanloo G; Nozarian Z; Sarrafpour B; Motahhary P
    Arch Iran Med; 2008 Sep; 11(5):561-2. PubMed ID: 18759528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sclerosing stromal tumor of the ovary: a case report and literature review].
    Charfi Darghouth L; Goutallier Ben Fadhel C; Lahmar A; Mestiri H; Khalfallah MT; M'Zabi Regaya S
    Tunis Med; 2007 May; 85(5):430-2. PubMed ID: 17657934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression.
    Park CK; Kim HS
    Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract.
    Nogales FF; Stolnicu S; Harilal KR; Mooney E; García-Galvis OF
    Histopathology; 2009 Mar; 54(4):471-7. PubMed ID: 19309399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex cord-stromal tumours of the ovary. A clinicopathological spectrum.
    Pai RR; Raghuveer CV; Jayasree A; Kini H
    Indian J Pathol Microbiol; 2000 Apr; 43(2):113-21. PubMed ID: 11217265
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.